Charles River Laboratories International, Inc.
CRLNYSEHealthcare● Active
$192.68
+$6.24(+3.35%)
Market Cap$9.3B
P/E Ratio—
52W High$228.88
52W Low$143.06
Charles River Laboratories International, Inc. (CRL) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CRL · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.21B | $0.19B | $0.28B | $0.23B | $0.25B |
| Net Receivables | $0.71B | $0.72B | $0.78B | $0.75B | $0.65B |
| Inventory | $0.30B | $0.28B | $0.38B | $0.26B | $0.20B |
| Total Current Assets | $1.45B | $1.40B | $1.61B | $1.44B | $1.27B |
| PP&E Net | $2.02B | $2.02B | $2.03B | $1.86B | $1.58B |
| Goodwill | $2.76B | $2.85B | $3.10B | $2.85B | $2.71B |
| Intangible Assets | $0.34B | $0.72B | $0.86B | $0.96B | $1.06B |
| Total Assets | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B |
| Liabilities | |||||
| Short-Term Debt | $0.06B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.15B | $0.14B | $0.17B | $0.21B | $0.20B |
| Total Current Liabilities | $1.12B | $0.99B | $1.06B | $1.09B | $1.03B |
| Long-Term Debt | $2.55B | $2.24B | $2.65B | $2.71B | $2.92B |
| Total Liabilities | $3.92B | $4.02B | $4.54B | $4.58B | $4.43B |
| Stockholders Equity | |||||
| Retained Earnings | $1.39B | $1.81B | $1.89B | $1.43B | $0.98B |
| Total Stockholders Equity | $3.16B | $3.46B | $3.60B | $2.98B | $2.53B |
| Total Liab & Equity(computed) | $7.09B | $7.48B | $8.13B | $7.56B | $6.97B |
| Debt Summary | |||||
| Total Debt | $3.07B | $2.72B | $3.07B | $3.10B | $3.21B |
| Net Debt | $2.85B | $2.53B | $2.79B | $2.86B | $2.96B |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Charles River Laboratories International, Inc. data
About Charles River Laboratories International, Inc. (CRL) Balance Sheet
Charles River Laboratories International, Inc. (CRL) balance sheet shows total assets of $7.14B with cash of $0.21B. Total liabilities are $3.92B, total debt $3.07B, and stockholders equity $3.16B.
Frequently asked questions
CRL · 4 questionsCharles River Laboratories International, Inc. has total debt of $3.07B with net debt of $2.85B.
CRL total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10